Filing Details
- Accession Number:
- 0001127602-11-032978
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-21 11:10:56
- Reporting Period:
- 2011-12-19
- Filing Date:
- 2011-12-21
- Accepted Time:
- 2011-12-21 11:10:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219016 | W Michael Bonney | 65 Hayden Avenue Lexington MA 02421 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-12-19 | 130,100 | $35.32 | 265,533 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-12-19 | 130,100 | $38.61 | 135,433 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-12-20 | 19,900 | $35.32 | 155,333 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-12-20 | 19,900 | $39.15 | 135,433 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2011-12-19 | 130,100 | $0.00 | 130,100 | $35.32 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2011-12-20 | 19,900 | $0.00 | 19,900 | $35.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,900 | 2002-04-03 | 2012-01-03 | No | 4 | M | Direct |
| 0 | 2002-04-03 | 2012-01-03 | No | 4 | M | Direct |
Footnotes
- Sold pursuant to a 10(b)5-1 Plan
- This transaction was executed in multiple trades at prices ranging from $38.2400 to $39.2900. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to privde upon request to the SEC staff, the issuer or a secruity holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
- This transaction was executed in multiple trades at prices ranging from $38.8400 to $39.2300. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to privde upon request to the SEC staff, the issuer or a secruity holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
- Option vests 6.25% quarterly over a four-year period.
Billionaire Hedge Funds
